Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1115418 BOSTON, MA
Back to AGIO Full portfolio

Position in AGIO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,948,055
+$465,982 QoQ
Shares Held
79,441
+8.3% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 17% Shared 0% None 83%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. AGIO ranks #77 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in AGIO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,948,055 79,441
2026-03-31 $2,482,073 73,369
2025-12-31 $2,018,444 74,153
2025-09-30 $3,520,358 87,702
2025-06-30 $2,989,442 89,881
2025-03-31 $2,544,470 86,842
2024-12-31 $3,105,532 94,508
2024-09-30 $4,186,327 94,223
2024-06-30 $4,362,881 101,180
2024-03-31 $2,986,866 102,150
2023-12-31 $2,238,090 100,498
2023-09-30 $2,527,519 102,122
2023-06-30 $2,856,978 100,882
2023-03-31 $2,099,572 91,405
2022-12-31 $2,506,645 89,268
2022-09-30 $2,458,832 86,946
2022-06-30 $1,810,291 81,655
2022-03-31 $2,196,524 75,456
2021-12-31 $2,687,615 81,765
2021-09-30 $3,969,084 86,004
2021-06-30 $4,879,935 88,549
2021-03-31 $3,574,417 69,218
2020-12-31 $3,080,069 71,084
2020-09-30 $2,367,890 67,654
2020-06-30 $3,731,994 69,783
2020-03-31 $2,266,001 63,867